CAS 250583-09-6 | ATRA-027 : Atrasentan
(World's Largest Pharmaceutical Supplier)
- CAS Number: 250583-09-6
- Stock: 999g
- Assay: 0.00%
CAS 250583-09-6 is a chemical compound with the molecular formula C24H29NO3. It is also known as 3-(1,3-Benzodioxol-5-yl)-1-(2,3-dihydroxypropyl)-4-methylpiperidine-4-carboxylic acid methyl ester. This compound is a white to off-white powder with a molecular weight of 395.49 g/mol.
Chemical Properties:
CAS 250583-09-6 is soluble in organic solvents such as DMSO and ethanol, but it is practically insoluble in water. It has a melting point of 130-135°C and a boiling point of 584.7°C at 760 mmHg. The compound has a density of 1.22 g/cm3 and a refractive index of 1.581.
Applications:
CAS 250583-09-6 is a potent and selective inhibitor of the enzyme dipeptidyl peptidase IV (DPP-IV), which is involved in the regulation of glucose metabolism. It has been extensively studied for its potential use in the treatment of type 2 diabetes mellitus. The compound has been shown to increase insulin secretion and decrease glucagon secretion, resulting in improved glycemic control.
In addition to its use in diabetes treatment, CAS 250583-09-6 has also been investigated for its potential use in the treatment of other diseases such as obesity, inflammatory bowel disease, and cancer. The compound has been shown to have anti-inflammatory and anti-tumor properties, and it has been suggested that it may have a role in the prevention and treatment of these conditions.
Conclusion:
CAS 250583-09-6 is a promising compound with potential therapeutic applications in the treatment of various diseases. Its ability to selectively inhibit DPP-IV and improve glycemic control makes it a valuable candidate for the treatment of type 2 diabetes mellitus. Further research is needed to fully explore its potential in the treatment of other diseases and to determine any potential side effects or interactions with other medications.